SCHEMBL19564263

SCHEMBL19564263

Cc1ccc(N(c2ccccc2)c2ccc3cc4c5cc(-c6ccccc6)cc6c7cc8ccc(N(c9ccccc9)c9ccc(C)cc9)cc8cc7n(c4cc3c2)c56)cc1

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ CYP2A6 P11509 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19564258 0.99 HTT (0.33) HTTNPSR1L3MBTL1MEN1KMT2A
SCHEMBL19564089 0.94 KDM4E (0.31) L3MBTL1TDP1
SCHEMBL19564254 0.93 MAPT (0.32) KMT2ATDP1
SCHEMBL19564267 0.93 — —
SCHEMBL19564165 0.93 TSPO (0.30) L3MBTL1TDP1
SCHEMBL19564272 0.93 TSPO (0.30) L3MBTL1TDP1
SCHEMBL19564323 0.91 KDM4E (0.31) MEN1KMT2A
SCHEMBL19564262 0.91 — —
SCHEMBL19564271 0.90 IP6K1 (0.31) —
SCHEMBL19564266 0.90 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 — — US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 — — US disclosed
US-20200365812-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-11-19 — — US disclosed
US-20190097142-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-03-28 — — US disclosed
US-10230058-B2 Compound, organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-03-12 — — US disclosed
US-20180198076-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-12 — — US disclosed
US-20180198076-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-12 — — US disclosed
US-9954187-B2 Compound, organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-04-24 — — US disclosed
US-9954187-B2 Compound, organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-04-24 — — US disclosed
US-20170324045-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-11-09 — — US disclosed
US-20170324045-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190097142-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE LEF1, L1CAM, EMC1 HTT 4674/4885NPSR1 4706/4885L3MBTL1 161/4885
US-20180198076-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE LEF1, L1CAM, EMC1 HTT 4674/4885NPSR1 4706/4885L3MBTL1 161/4885
US-20170324045-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE LEF1, L1CAM, EMC1 HTT 4674/4885NPSR1 4706/4885L3MBTL1 161/4885
US-10230058-B2 Compound, organic electroluminescence device and electronic device LEF1, L1CAM, EMC1 HTT 4674/4885NPSR1 4706/4885L3MBTL1 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback